Volume 14, Issue 6 (Nov & Dec 2024)                   J Research Health 2024, 14(6): 575-586 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rezapour M, Khanjani N, Sharafkhani R, Moosazadeh M. Multimorbidity Patterns and Their Relationship With ICU Admission and Mortality Rates in Hospitalized Patients With COVID-19 in Northern Iran. J Research Health 2024; 14 (6) :575-586
URL: http://jrh.gmu.ac.ir/article-1-2432-en.html
1- Department of Paramedicine, Amol School of Paramedical Sciences, Mazandaran University of Medical Sciences, Sari, Iran.
2- Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran.
3- Department of Public Health, Khoy University of Medical Sciences, Khoy, Iran.
4- Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran. , mmoosazadeh1351@gmail.com
Abstract:   (1000 Views)
Background: Classifying COVID-19 hospitalized patients based on multimorbidity could aid in individual evaluation and provide effective triage for better treatment and management. The aim of this study was to extract multimorbidity patterns among hospitalized COVID-19 patients and determine their associations with admission to intensive care units (ICU) and mortality. 
Methods: The data in this retrospective study were acquired from the registry system for all 13,960 COVID-19 patients from 42 hospitals in Mazandaran Province in northern Iran between March 20, 2020, and July 20, 2021. The multimorbidity patterns of 11 chronic diseases were extracted using latent class analysis (LCA). The association between multimorbidity patterns and mortality from COVID-19 and admission to the ICU was examined using multilevel logistic regression modeling. 
Results: Four classes were identified, including diabetes and cardiovascular disease (class 1, 3.7%), metabolic diseases and others (class 2, 0.6 %), diabetes and hypertension (class 3, 23.0%), and non-multimorbidity (class 4, 72.7%). Membership in class 1 (diabetes and cardiovascular disease) and class 3 (diabetes and hypertension), compared with class 4 (non-multimorbidity), was associated with higher odds of experiencing death (OR=2.66 for class 1 and 1.21 for class 3). Class 2 did not show a significant difference from class 4 regarding mortality.
Conclusion: Multimorbidity classification is a key predictor of COVID-19 patient prognosis, guiding treatment decisions and prioritizing protective measures, such as vaccination. Notably, those with multimorbidity patterns of “diabetes and cardiovascular diseases” and “diabetes and hypertension” exhibit the highest risk of ICU admission and mortality. 
 
Full-Text [PDF 726 kb]   (204 Downloads) |   |   Full-Text (HTML)  (143 Views)  
Type of Study: Orginal Article | Subject: ● Disease Control
Received: 2023/09/24 | Accepted: 2023/12/23 | Published: 2024/10/28

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Research and Health

Designed & Developed by : Yektaweb